Precision Biosciences (DTIL) Gains from Investment Securities (2018 - 2026)
Precision Biosciences (DTIL) reported Gains from Investment Securities of $4000.0 for Q1 2026, up 144.44% year-over-year from $1636.4 in Q1 2025, and up 101.03% on a QoQ basis from -$390000.0 in Q4 2025.
Precision Biosciences (DTIL) has 9 years of Gains from Investment Securities data on file, last reported at $4000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 144.44% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$408000.0 (up 53.74% YoY) and the FY2025 annual result came in at -$421000.0, down 211.8% from the prior year.
- Gains from Investment Securities grew to $4000.0 in Q1 2026 per DTIL's latest filing, from -$390000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $13.8 million in Q3 2022 and bottomed at -$626000.0 in Q4 2023.
- The 5-year median for Gains from Investment Securities is $3000.0 (2025), against an average of $1.6 million.
- Peak annual rise in Gains from Investment Securities reached 860.9% in 2023, while the deepest fall reached 1204.17% in 2023.
- Tracing DTIL's Gains from Investment Securities over 5 years: stood at -$48000.0 in 2022, then sank by 1204.17% to -$626000.0 in 2023, then soared by 70.93% to -$182000.0 in 2024, then tumbled by 114.29% to -$390000.0 in 2025, then jumped by 101.03% to $4000.0 in 2026.
- Per Business Quant, the three latest DTIL Gains from Investment Securities figures stand at $4000.0 (Q1 2026), -$390000.0 (Q4 2025), and $3000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | -390,000.00 |
| Dec 31, 2025 | -390,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Sep 30, 2024 | 23,427.00 |
| Sep 30, 2024 | 23,427.00 |
| Jun 30, 2024 | 348,794.00 |
| Jun 30, 2024 | 348,794.00 |
| Mar 31, 2024 | -65,000.00 |
| Mar 31, 2024 | -65,000.00 |
| Dec 31, 2023 | -626,000.00 |
| Dec 31, 2023 | -626,000.00 |
| Sep 30, 2023 | 453,481.00 |
| Sep 30, 2023 | 453,481.00 |
| Jun 30, 2023 | 12.52 Mn |
| Jun 30, 2023 | 12.52 Mn |
| Mar 31, 2023 | -7,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -48,000.00 |
| Dec 31, 2022 | -48,000.00 |
| Sep 30, 2022 | 13.81 Mn |
| Sep 30, 2022 | 13.81 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 739,815.00 |
| Mar 31, 2022 | 739,815.00 |
| Dec 31, 2021 | -17.92 Mn |
| Dec 31, 2021 | -17.92 Mn |
| Sep 30, 2021 | 9.62 Mn |
| Sep 30, 2021 | 9.62 Mn |
| Jun 30, 2021 | 332,860.00 |
| Jun 30, 2021 | 332,860.00 |
| Mar 31, 2021 | 6.80 Mn |
| Mar 31, 2021 | 6.80 Mn |
| Dec 31, 2020 | -8.24 Mn |
| Dec 31, 2020 | -8.24 Mn |
| Sep 30, 2020 | 10.42 Mn |
| Sep 30, 2020 | 10.42 Mn |
| Jun 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 102,537.00 |
| Mar 31, 2020 | 102,537.00 |
| Dec 31, 2019 | -5.32 Mn |
| Dec 31, 2019 | -5.32 Mn |
| Sep 30, 2019 | 2.12 Mn |
| Sep 30, 2019 | 2.12 Mn |
| Jun 30, 2019 | 998,177.00 |
| Jun 30, 2019 | 998,177.00 |
| Mar 31, 2019 | 141,000.00 |
| Mar 31, 2019 | 141,000.00 |
| Dec 31, 2018 | 1.41 Mn |
| Dec 31, 2018 | 1.41 Mn |
| Jun 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -3,000.00 |